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ABSTRACT
Background There appears to be considerable variation
between different national jurisdictions and between
different sectors of public policy in the use of evidence
and particularly the use of randomised controlled trials
(RCTs) to evaluate non-healthcare sector programmes.
Methods As part of a wider study attempting to identify
RCTs of public policy sector programmes and the
reasons for variation between countries and sectors in
their use, we carried out a pilot study which interviewed
10 policy makers and researchers in six countries to elicit
views on barriers to and facilitators of the use of RCTs
for social programmes.
Results While in common with earlier studies, those
interviewed expressed a need for unambiguous findings,
timely results and significant effect sizes, users could, in
fact, be ambivalent about robust methods and robust
answers about what works, does not work or makes no
difference, particularly where investment or a policy
announcement was planned. Different national and policy
sector cultures varied in their use of and support for RCTs.
Conclusions In order to maximise the use of robust
evaluations of public programmes across the world it
would be useful to examine, systematically, cross-
national and cross-sectoral variations in the use of
different methods including RCTs and barriers to and
facilitators of their use. Sound research methods,
whatever their scientific value, are no guarantee that
findings will be useful or used. ‘Stories’ have been shown
to influence policy; those advocating the use of RCTs
may need to provide convincing narratives to avoid
repetition about their value.
BACKGROUND
Twenty-three researchers recently signed a paper in
the Lancet arguing for the mandatory impact
evaluation of public policies, pointing to the need
for ‘better use of research evidence to improve
decisions about public programmes both interna-
tionally and nationally ’ and emphasising the lack
of rigour of most evaluations.1 In a similar vein, the
House of Commons Health Select Committee
noted the poor quality of much evaluation in social
and public health policy in the UK:
“The most damning criticisms.we have heard in this
enquiry [have been] of the Government’s approach to
designing and introducing new policies which make
meaningful evaluation impossible.Even where
evaluation is carried out, it is usually.little more
than.asking those involved what they thought about
them”.2
Although the use of experimental designs such as
randomised controlled trials (RCTs) is generally
uncontentious in medicine, this has not been the
case in social policy circles in the UK. Arguments
against RCTs of social programmes (eg, in the ﬁelds
of transport, housing, criminal justice, education
and early childhood development) have tended to
focus on potential problems with feasibility, ethics,
cost, public and professional acceptability and
generalisability.3 While we do not advocate the use
of RCTs for all programmes,4 5 we do think that
many of these objections are overemphasised,
particularly since some countries, including the
USA, have a long history of using RCTs of social
programmes.3 6 However, other countries have
tended to avoid using controlled trials,7 and this
raises questions about the extent to which different
sectors, and different national jurisdictions, value
and use different types of research. Given the
considerable international variation in the use of
social experiments, attempts to understand the
cultural and practical barriers which policy makers
and commissioners in different sectors face in the
use of research evidence internationally may be
useful. Lessons might be learnt from the imple-
mentation of RCTs in different national contexts.
As part of the International Collaboration for
Complex Interventions (http://www.intervention-
research.ca/), we conducted a pilot study to assess
the extent to which it is possible to (a) identify
how many RCTs have been undertaken of social
policy programmes in different countries and (b)
interview public policy makers and advisors in
a range of different countries about the use of RCTs
for social programmes. Our review of the preva-
lence of RCTs showed numerous examples across a
wide range of social- and health-related programmes
(eg, injury prevention, school feeding, day care for
school-age children, delinquency prevention) but
wide variation in their prevalence between sectors
and particularly between nations.8
Here, we report on ﬁndings from the interviews,
which were designed to collect qualitative data
exploring the conditions under which RCTs may
and may not be feasible: the barriers to and
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facilitators of the development of new trials and the ways in
which different kinds of evidence are valued within policy
sectors including health, criminal justice, education and social
welfare. These interviews were an extension of our previous
work, which had examined policy makers and researchers’
experiences of the use of different types of evidence in public
health in the UK.9 10 While the debate about the place of RCTs
in evaluating social policies is not new, we focus on the potential
added value of RCTs as opposed to other forms of research and
how this is perceived in different areas of public policy, and in
different countries. Interviews with elites in this ﬁeld are still
relatively rare, as is exploration of differences in the acceptability
of social experiments between sectors and between countries.
METHODS
For this pilot, we selected the USA, Canada, Australia, New
Zealand, England and Scotland because the former two countries
made most use of RCTs and the UK least and Australia and New
Zealand were in the middle. Their political and welfare systems
varied and we could easily identify key policy makers and
researchers in these countries to interview. An open-ended
interview topic guide was designed by KL, amended in discus-
sion with the team and adapted at interview according to
whether the respondent was a policy maker, commissioner of
research or researcher. Further details can be found in our
report.8
Policy is inﬂuenced not just by ofﬁcials and politicians but also
by researchers with the ear of policy makers and/or whose
results have been useful or used in the past. Our sample was
selected to include (a) those in a position to inﬂuence policy
(including funding and research policies) and (b) individuals we
considered to be familiar with the extent to which different
research methods are (or in some cases are perceived to be) more
or less appropriate to support decision making. Funders can have
a substantial effect on evaluative methods: for instance Euro-
pean Union funding differs from North American funding in its
emphasis on process evaluations as compared with trials.11
We approached 15 individuals for an interview. None refused to
participate, but a ﬁrm commitment was not forthcoming within
our timescale from ﬁve interviewees. We interviewed 10 individ-
uals from the six countries: six by telephone and four face to face.
They were all professionals in the public sector and worked in
a range of ﬁelds including criminal justice, education, public
health and social care. Eight were involved with policy or research
commissioning and two were senior researchers, one of whom
had also been involved in commissioning (though not simulta-
neously). Interviews were audio taped and transcribed, with
participant consent, and the transcripts were read by at least two
of the researchers who agreed on emergent themes. In this pilot
study, there were too few countries, policy sectors and policy
advisory roles represented to undertake systematic comparisons
between countries, policy sectors or roles. The main barriers and
levers to the use of trials are described in table 1. Here, we restrict
our ﬁndings to interviewees’ observations on different policy
sectors and the relative importance of different types of evidence.
To protect conﬁdentiality, the quotations below do not give
identifying details. However, they represent all 10 interviewees
and all six countries. Identifying information is provided as
appropriate on sector.
FINDINGS
The main ﬁnding from our pilot interviews was that it was
possible and informative to interview relatively elite policy
advisers, in a range of countries, and that useful insights on
barriers and facilitators to the use of RCTs could be obtained in
this way.
What is the ‘added value’ of RCTs to users compared with other
study designs?
All interviewees were asked about the extent to which the
methodological robustness of RCTs is valued compared with
other study designs and other types of information.
One policy advisor in education spoke in terms of a “Sliding
scale; at the bottom end an unvalidated advocacy message.might
instigate further research, but the scale goes from this to the.RCT.or
systematic review or meta-analysis.”
A senior researcher and user of research in public health,
experienced in evaluating policy and in liaising with policy
makers, spoke of the power of trials to inﬂuence policy makers:
“I would tend naturally to have more conﬁdence in the results,.
assuming that it wasn’t just the design but the implementation of it
that was satisfactory.the advantage is that even politicians would
tend to be inﬂuenced by something that was convincingly a controlled
trial.”
Another policy advisor in social care concurred, noting the
advantages over observational methods: “.it’s difﬁcult to get the
high quality of analysis other than through an RCTdwhere possible it
should be an RCT.”
A senior manager responsible for policy development in the
ﬁeld of education also claimed that well-controlled experiments:
“.do tend to solve arguments.. People respect them.” However, s/he
went on to note that this did not always apply to researchers in
government “Up until a wee while ago, our research division was very
unsympathetic, if not downright antagonistic to, randomised trials.” A
related point was made by a social and public policy adviser, to
the effect that researchers do not give policy makers clear advice
on when to use particular research methods, and experiments
were often downplayed:
“Policy makers are getting.rather mufﬂed messages about when to do
a trial or.when some other method will do.so it’s hardly surprising that
they are.quite happy to.go on using weaker methods,.they’re not
getting a clear steer.the choices they’re given don’t involve the option of
running a trial. .There are.quite inﬂuential papers about the
methodology in evaluating social interventions which give policy makers
a lot of rope to hang themselves.”
However, in the experience of a senior education/health
researcher, who had designed a number of innovative RCTs of
social interventions, it was not trial methodology but instead
the ability to attribute costs and beneﬁts to interventions that
mattered: “It’s still the calculus of policy.” Asked whether the
ﬁndings of the RCTalone would have had the same weight, s/he
continued “some, but the cost-beneﬁt analysis was the big factor.a
number of ministers have said it made a big difference to them being
able to argue the case.”
Sound methods s useable findings
The senior ofﬁcial in education quoted above was someone who
needed to use research but was critical of the sort of research
knowledge s/he received: “A lot of research knowledge is not helpful
from my perspective.” While this might seem to imply that
‘stronger’ methods would be more useful, this was not necessarily
the case. Even among vigorous advocates of trials, it was clear
that sound methods did not necessarily lead to useable ﬁndings:
“As you move up that scale, there [are] more useful ‘ﬁndings’ in terms of
their scientiﬁc validity. Whether they translate into a discourse that you
can hold with policy makers is another question.”
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A policy advisor, experienced in using and commissioning
RCTs in the ﬁeld of healthcare, and an advocate of their wider
use for social policy concurred: “By and large, methodology is
a weak inﬂuence in the sense that policy makers don’t really tend to
weigh up research evidence in terms of the strength of the source, it’s
much more the signal that they’re interested in.”
S/he felt that policy makers tended to prefer “very small scale
studies, pilots, rather informal evaluation evidence where it supports
what they’re interested in doing, and [they are].quite resistant to the
much stronger evidence where it doesn’t support what they think.”
Another policy advisor, who had worked in several govern-
ment departments and was a strong advocate of the greater use
of social experiments, was similarly less than optimistic about
the impact of trials:
“Certainly in [my country], the power of a story beats almost
anything.If researchers would ﬁnd a story to tell about their RCT, or
personalise it.If you’re dealing with.politicians, you have to.appeal
with a story.”
One reason for the underuse of RCTs which emerged from the
interviews was that paradoxically, the straight answers
described by some interviewees as useful in settling questions
could be perceived as unhelpfuldparticularly when they show
that favoured interventions do not ‘work’:
“.if the results tell you that your intervention isn’t working then you’re in
trouble.to some extent, people would rather have vaguer information
about processes, which.carries less risk.I mean, people like the idea of
the process of continuous quality improvement with evaluation,
contributing something to improve the way you implement your.new
policy or your intervention, and I think, to some extent, that’s preferred to
evidence which.tell(s) you pretty starkly that you ought to stop and that
you’re wasting public money.”
A government research commissioner in the area of social care
observed: “You can’t necessarily say it’s one type of research over
another type, because the type of design depends on the kind of research
question you’re asking. Different types of research will be valuable in
different contexts.”
Speciﬁc barriers to and facilitators of the use of RCTs, as
opposed to evidence more generally, about which much has
already been written12 13 were also identiﬁed. The perceived lack
of ﬂexibility of RCTs, particularly in relation to the adaptability
of programmes by practitioners, plus high costs and long
timescales were referred to in several cases.
Interviewees suggested that RCTs are underused because users
are more interested in evaluation being used strategically to
demonstrate policy interest:
“There are quite complicated reasons for commissioning evaluations and
they’re not all about testing how things work. A lot of them are to do
with.demonstrating that you are taking the issue seriously.”
This political function of evaluation was highlighted by
a former Treasury ofﬁcial who pointed to the importance of
presentation and language:
“There was ministerial reluctance to appear to be just trying something
out, or not to give something to one group who might be equally eligible. We
did point out that.we did this kind of thing anyway in practice, but they
were happier if we called it a pilot rather than an experiment or a trial.”
One UK policy adviser made an interesting point about the
intellectual background of politicians:
“versed in the law and advocacy and case study and precedent, rather
than science.”
Asked for any examples of unsuccessful attempts to set up
policy RCTs, an interviewee drew on the example of an early
years intervention involving early education, childcare, health
and family support where the evaluation funded was not a RCT:
“All the scientists were saying it should be an RCT, but.in this
country, the service delivery people don’t have the faith that it’s
important to evaluate things in a very rigorous way, and they felt it
was more important to have services which could be adapted to local
situations.”
The use of experiments by different sectors/countries
One policy maker who had worked across different sectors
noted that:
“Health.says it takesdrandomised trials much more seriously than
other sectors. It certainly takes evidence more seriously.[Problem area]
certainly doesn’t rely on high quality [evidence], in this sector, we do
Table 1 Barriers to and facilitators of social policy trials identified with interviewees
Levers Barriers
Personal contacts/researcher policy contact/serendipity Poor communication by researchers; ambivalence/hostility by researchers and
research brokers
Potential for good cost-benefit information
Independence of evaluators from policy/politicians Problems if policy initiative to which politicians have committed themselves
shown not to work
Funding for new initiatives tied to good trial evidence/accountability Cost/complexity of running a trial
Advocacy by those whose trials have shown an effect in other countries Ambivalence/hostility by some researchers and research brokers
Good dissemination skills by trialists; willingness to avoid too many caveats
when presenting results
Over-enthusiasm by some trial proponents
A lot of good research on what the problems are; less on what to do about them Pejorative use of term ‘experimentation’
Convincing trial welcome to politicians Lack of high-quality trial applications
Support from key government departments (eg, Treasury) Moral and ethical concerns/equipoise
Lack of researcher experience in social policy trials
Recruitment problems
Timing (in relation to policy development)/political desire to get things up
and running quickly
RCTs more suited to clinical research
The line of least resistance not to carry them out
Culture of advocacy, case study, precedent and anecdote
RCTs, randomised controlled trials.
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things, futile things, inappropriate things, [more] than even the health
sector or the housing sector or any other, because we’re always in a rush.
Nobody [in this area] prides themselves on being an expert [in the]
evidence-based sector.It’s a bizarre system.it’s much more
dysfunctional than health.the primacy of research is not there.”
A commissioner and user of research suggested, however, that
while there was apparently greater use of RCTs in health, this
was accompanied by a range of other types of evidence:
“Public health professionals in particular are used to working without
RCTevidence, for example when there is a disease outbreak, or some other
crisis. There, decisions tend to be driven by theoretical constructs tested in
related health issues, by basic biological evidence, plus aetiological
evidence, and evidence of what’s going on in the community, plus evidence
on behaviour changedthat is, a series of sources of information/evidence.”
Reﬂecting on the lesser use made of RCTs in sectors other
than health, another interviewee said that in [country], RCTs
are used as a tool to cut funding, rather than to simply identify
‘what works’:
“The [country] Department of Education.led to a push for more
RCTs in education.Now, RCTs and systematic reviews are used as
a way of cutting programmesdwhere there is no good evidence from
RCTs, it is used to justify a cut.” S/he expanded this theme of
cultural differences in use of experimentation, drawing
comparisons between countries:
“[It] relates to levels of afﬂuence and the degree of development of the
scientiﬁc community but in Europe my impression is that Northern Europe
has done a lot more in terms of social and health research of an organised
type.In the Scandinavian countries you have a tradition of really
being.organised and imposing quite high degrees of control over the
population in terms of what people can and can’t do, and gathering a lot
of data on a large scale.whereas in Southern Europe, they have less of
a history of social public health trials. The United States and Canada in
terms of volume (not necessarily quality) is far ahead of the rest. Australia
has done quite a bit given the size of the country as well.”
S/he went on to explain why this may be so; in some coun-
tries, evaluation is important for public accountability:
“In [our country], we have a very strong tradition of evaluation research
and population-based epidemiology. This is linked to the need for
accountability for performancedas opposed to seeking harder evidence of
effectiveness.”
Another interviewee noted that educational researchers’
“methodological tool-kits tend to be in other areas” and that they
assume that RCTs are only of value in medicine.
The single trialist we interviewed noted that many countries
placed more weight on studies from abroad, and publication in
a US journal was often more prestigious. S/he suggested that
one argument posed against trials in the education setting was
that it is not fair to deprive someone of an intervention which
they perceive as being effective.
The US emphasis on trials was also underlined by a former
policy maker:
“Very strong in the US and possibly in CanadadI have that impression.
We’re somewhere in the middle. The Europeans are nowhere. There’s no
interest in continental Europe. It’s an Anglo-Saxon disease.”
Training in appropriate skills was identiﬁed as a problem in
several cases, for example, a UK Research Commissioner said:
“I think I ﬁnd it quite dispiriting that in America, they will invest in these
really rigorous studies, and yet in this country, we don’t. There’s a problem
with research capability in this country because people don’t develop the
skills to do it.”
Finally, interviewees reﬂected on what additional information
is needed beyond RCTs. Suggestions included studies that
permit comparisons between countries and studies which
describe context: “Useful information includes studies that illuminate
the extent and the nature of the problem. [Our country] pays a lot
of attention to the PISA study, by the OECD, which includes 40
countries.comparative studies are helpful.”
DISCUSSION
This small pilot suggested considerable diversity between
countries and between sectors in the experience of and attitudes
towards the use of RCTs for social programmes. Political
cultures, both in the sense of national jurisdictions and partic-
ular disciplines and sectors, were seen to shape the perceived
acceptability and desirability of, and responses to, RCTs.
Arguments against RCTs of social programmes have tended to
focus on potential problems with feasibility, ethics, cost, public
and professional acceptability and generalisabilitydarguments
to which Macintyre,3 Oakley14 and others have responded. Our
preliminary ﬁndings suggest that if RCTs are to be used more
generally, additional concerns may need to be addressed.
McKee15 has described the inﬂuence of political ideologies on
the conduct and use of RCTs in medicine, and we know that
there are political impediments to robust evaluation in many
healthcare areas.16 Our interviews suggest that there are similar
inﬂuences on the conduct of social policy RCTs, with there being
arguments in particular in education about appropriate evalua-
tion methods. While not wanting to re-invent the wheel, sectors
may prefer their own wheel. This may account in part for the
common hostility to trials in other sectors, stemming from their
view of RCTs as being ‘over medical’ (despite their early use in
the social sciences6).
Our interviews pose challenges for advocates of robust
evaluation methods. Much debate about evidence-based public
policy and gaps in the evidence base in public health and
elsewhere are predicated on the assumption that there is
a supply-side problem: researchers have failed to do the right
kind of evaluation in the past. This may well be true, but our
interviews illustrate that there may also be signiﬁcant prob-
lems on the demand side. Users do not always want robust
methods because they do not always want robust answers
about what works. Thus, the production of better evidence
alone will not necessarily lead to its uptake (and in any case,
political values and other factors legitimately play a role in
policy decision making).
Previous studies have also pointed to the proliferation of
terms to describe evaluation studies. Walker and colleagues17 in
describing the implementation of a social experiment, the
Employment Retention and Advancement (ERA) trial refer to
a ‘cacophony of names’: pilots, pathﬁnders, experiments and so
on, suggesting that this may be less to do with capturing the
richness of evaluation methods than with obscuring the exper-
imental (in the non-scientiﬁc sense of the word) nature of most
public policy. According to a report on ‘pilots’ in UK policy-
making, civil servants and ministers may themselves sometimes
be confused about the distinctions between different policy-
testing mechanisms. That report also described how a Minister
had been given the option to choose a name that s/he liked best
for a ‘pilot’ from a range of options.18
While the study we report here was planned only as a pilot,
it provides a contribution in moving the debate beyond the
need to produce robust evidence, important though that is to
how its value to users may be enhanced and how the use of
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RCTs may be encouraged. Much previous research in this ﬁeld
has noted the impact of a ‘good story ’9 10 19 20 or ‘killer facts’21
and the fact that those on the receiving end of policies and
services may also prefer to present their data through stories.22
It may be that if the debate on the use of research evidence to
inform policy is to move beyond the academic world,
convincing ‘stories’ and ‘killer facts’ need to be provided by
those advocating the use of RCTs to researchers, policy
advisers, politicians and those on the receiving end of social
programmes, rather than complex methodological arguments.
An example would be the ‘story ’ of the ‘scared straight’
programmes in the USA, where all the process and user
reported information suggested that it was highly effective, but
a meta-analysis of seven RCTs showed it to be counter
productive.23
This pilot suggests that it would be feasible and instructive to
undertake a more extensive study, systematically comparing
countries and sectors in relation to the use of RCTs and their
barriers and facilitators.
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What is already known on this subject
< Randomised controlled trials (RCTs) are more generally
accepted in clinical medicine than in public health and much
less often used for programmes in sectors such as social care,
transport, criminal justice, housing and education which may
influence health.
< There are cross-national, and policy sector, differences in the
use of RCTs for evaluating social programmes.
< ‘Stories’ may influence policy-making more than methodologically
robust evidence.
What this study adds
< It is possible to generate useful insights about cross-national
and policy sector differences in the use of RCTs, which might
help elucidate the barriers and facilitators for RCTs and the
context in which they might be acceptable and useful.
< If advocating for RCTs for social programmes, account would
need to be taken of political cultures in different jurisdictions
and the cultures of particular disciplines and sectors.
< Clear results (often presented as a selling point for the use of
RCTs) may, in fact, be a barrier, particularly where they cast
doubt on a substantial investment or a policy announcement
already made or planned.
< ‘Stories’ about the practical value of RCTs may be more
convincing than detailed methodological arguments about
their merits.
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